Completed PHASE3 INTERVENTIONAL 3-arm NCT04347733

Hyaluronidase in Intra-articular Steroid Injection Treating the Adhesive Capsulitis for Shoulder

Additive Effects of Hyaluronidase in Intra-articular Steroid Injection Treating the Initial Stage of Adhesive Capsulitis for Shoulder

Sponsor: Veterans Health Service Medical Center, Seoul, Korea

Conditions Adhesive Capsulitis of Shoulder

Interventions Hyaluronidase Injection Triamcinolone Acetonide 40mg/mL

Updated 5 times since 2020 Last updated: Apr 13, 2020 Started: May 2, 2017 Primary completion: Mar 27, 2019 Completion: Jul 16, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Adhesive Capsulitis of Shoulder, this trial is completed. The trial is conducted by Veterans Health Service Medical Center, Seoul, Korea and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
May 2020 — Jan 2021 [monthly]

Completed PHASE3

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Veterans Health Service Medical Center, Seoul, Korea

Data source: Veterans Health Service Medical Center, Seoul, Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea